Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators-Reference-Cited by-同舟云学术

Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators

Published:2022-11-04 Issue: Volume: Page:
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Del Giudice Francesco¹²^ORCID,D'Andrea David³^ORCID,Pradere Benjamin³⁴,Berndl Florian³,Pallauf Maximilian³^ORCID,Flammia Rocco Simone¹^ORCID,Philipp Dominik³,Moschini Marco⁵^ORCID,Mari Andrea⁶^ORCID,Albisinni Simone⁷^ORCID,Krajewski Wojciech⁸,Laukhtina Ekaterina³^ORCID,Gallioli Andrea⁹^ORCID,Mertens Laura S.¹⁰^ORCID,Marcq Gautier¹¹¹²,Cimadamore Alessia¹³^ORCID,Afferi Luca¹⁴^ORCID,Gontero Paolo¹⁵,Shariat Shahrokh F.³¹⁶¹⁷¹⁸¹⁹,Chung Benjamin I.²^ORCID,Soria Francesco¹⁵^ORCID

Affiliation:

1. Department of Maternal Infant and Urologic Sciences ‘Sapienza’ University of Rome, Policlinico Umberto I Hospital Rome Italy

2. Department of Urology Stanford University School of Medicine Stanford CA USA

3. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria

4. Department of Urology La Croix du Sud Hospital Quint Fonsegrives France

5. Department of Urology San Raffaele Hospital and Scientific Institute Milan Italy

6. Unit of Oncologic Minimally‐Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital University of Florence Florence Italy

7. Urology Department Erasme Hospital, Université Libre de Bruxelles Brussels Belgium

8. Department of Urology and Oncological Urology Wrocław Medical University Wrocław Poland

9. Urology Fundacio Puigvert Barcelona Spain

10. Department of Urology The Netherlands Cancer Institute Amsterdam The Netherlands

11. Urology Department Claude Huriez Hospital, CHU Lille Lille France

12. Univ. Lille, CNRS, Inserm, CHU Lille Institut Pasteur de Lille, UMR9020‐U1277 – CANTHER – Cancer Heterogeneity Plasticity and Resistance to Therapies Lille France

13. Section of Pathological Anatomy, School of Medicine Polytechnic University of the Marche Region, United Hospitals Ancona Italy

14. Department of Urology Luzerner Kantonsspital Luzern Switzerland

15. Urology Division, Department of Surgical Sciences University of Studies of Torino Turin Italy

16. Department of Urology Weill Cornell Medical College New York NY USA

17. Department of Urology University of Texas Southwestern Dallas TX USA

18. Department of Urology, Second Faculty of Medicine Charles University Prague Czech Republic

19. Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15920

Reference17 articles.

1. Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience

2. Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?

3. Association between surgical case volume and survival in T1 bladder cancer: a need for centralization of care?;Wettstein MS;Can Urol Assoc J,2020

4. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer

5. Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508–15;European Urology Oncology;2023-11

2. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial;European Urology Oncology;2023-10

3. Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010;European Urology Oncology;2023-10

4. Repeat Transurethral Resection for Non–muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era;European Urology Focus;2023-07

5. En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?;Current Opinion in Urology;2023-01-09